As the heart progresses toward heart failure, it produces high levels of a protein called Osteopontin, which is known to activate pathological remodeling of the heart. Lina Shehadeh, Ph.D., assistant professor of medicine, and a team of investigators decided to see if they could find a way to block Osteopontin signaling to prevent — or possibly even reverse — heart failure.
As medicine and the delivery of health care continue to be transformed, the University of Miami Miller School of Medicine — already a national leader in innovative education — is taking a global look at transforming the entire medical curriculum. And Amar R. Deshpande, M.D., who is leading the charge as chair of the Next Generation Medical Education Task Force, says the timing couldn’t be better.
The Florida Department of Health announced Feb. 1 the award of 12 grants totaling $13,170,784 from the 2016-17 Zika Research Grant Initiative to investigators at the University of Miami Miller School of Medicine and the University of Miami Health System. The grants are more than half of the $25 million state fund supporting a total of 34 Zika research projects at UM and nine other institutions.